Fig. 8
From: Identification of PLA2G7 as a novel biomarker of diffuse large B cell lymphoma
Darapladib inhibits DLBCL cells proliferation and induced apoptosis. A: DB and SU-DHL-2 cells were incubated with increasing concentrations of darapladib for 72 h. Cell viability was determined with the CCK8 assay. B: Darapladib induced apoptosis in DB and SU-DHL-2 cells. C: The expression of PLA2G7 was significantly related to overall survival of DLBCL patients. Red and blue lines indicate high-expression and low-expression groups, respectively. ****P < 0.0001